|
Market Closed -
Nasdaq
21:00:00 10/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 94.42 USD | +1.33% |
|
+8.49% | +19.53% |
| 11-10 | Mirum Pharmaceuticals' Phase 3 Study of Chronic Hepatitis Delta Virus Treatment Meets Primary Endpoint | MT |
| 11-10 | Mirum's liver infection drug lowers virus levels in second late-stage study | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MIRM | Delayed | |
CBOE
| MIRM | Real-time | |
|
Deutsche Boerse AG
| 08D | Delayed | |
|
Tradegate
| 08D | Real-time | |
|
Börse Stuttgart
| 08D | Delayed | |
|
Boerse Muenchen
| 08D | Real-time | |
|
Xetra
| 08D | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 96.97 | 100.9 | 125.59 |
| Spread/Res. | -2.63% | -6.42% | -24.82% |
| Spread/Supp. | +9.71% | +19.14% | +45.26% |
| Support | 86.06 | 79.25 | 65 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MIRM Stock
- Charts Mirum Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
